论文部分内容阅读
目的:探讨头孢类药物联合阿奇霉素治疗支原体肺炎效果。方法:研究对象为该院2015年1~9月期间收治的80例支原体肺炎患者,分为对照组和观察组各40例,其中对照组运用阿奇霉素治疗,观察组运用头孢曲松钠联合阿奇霉素治疗,分析两组患者治疗效果差异。结果:治疗有效率上,观察组为97.5%,对照组为72.5%,两组差异显著(P<0.05);在发热、咳嗽、肺部啰音等症状消除时间与痊愈时长上,观察组均少于对照组(P<0.05)。结论:头孢类药物联合阿奇霉素治疗支原体肺炎可以提升治疗效果,快速改善疾病症状。
Objective: To investigate the effect of cephalosporin combined with azithromycin in the treatment of mycoplasma pneumonia. Methods: The subjects were 80 mycoplasma pneumonia patients admitted to our hospital between January and September 2015. The patients were divided into control group and observation group, 40 cases each. The control group was treated with azithromycin. The observation group was treated with ceftriaxone sodium and azithromycin , Analysis of two groups of patients with different treatment effects. Results: The effective rate of treatment was 97.5% in the observation group and 72.5% in the control group, with significant difference between the two groups (P <0.05). On the time of eliminating fever, cough, pulmonary rales and other symptoms, Less than the control group (P <0.05). Conclusion: The combination of cephalosporin and azithromycin in the treatment of mycoplasma pneumonia can improve the therapeutic effect and rapidly improve the symptoms of the disease.